Cetirizinum [Latin] en es it fr

Cetirizinum [Latin] Brand names, Cetirizinum [Latin] Analogs

Cetirizinum [Latin] Brand Names Mixture

  • No information avaliable

Cetirizinum [Latin] Chemical_Formula


Cetirizinum [Latin] RX_link


Cetirizinum [Latin] fda sheet

Cetirizinum_[Latin] FDA

Cetirizinum [Latin] msds (material safety sheet)

Cetirizinum [Latin] Synthesis Reference

E. Baltes et al., U.S. Pat. 4,525,358 (1985)

Cetirizinum [Latin] Molecular Weight

388.888 g/mol

Cetirizinum [Latin] Melting Point


Cetirizinum [Latin] H2O Solubility

101 mg/L

Cetirizinum [Latin] State


Cetirizinum [Latin] LogP


Cetirizinum [Latin] Dosage Forms


Cetirizinum [Latin] Indication

For the relief of symptoms associated with seasonal allergic rhinitis, perennial allergic rhinitis and the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria

Cetirizinum [Latin] Pharmacology

Cetirizine, the active metabolite of the piperazine H1-receptor antagonist hydroxyzine, is used to treat chronic idiopathic urticaria, perennial allergic rhinitis, seasonal allergic rhinitis, allergic asthma, physical urticaria, and atopic dermatitis.

Cetirizinum [Latin] Absorption

mean peak plasma concentration (Cmax) of 114 ng/mL at a time (Tmax) of 2.2 hours postdose was observed for cetirizine

Cetirizinum [Latin] side effects and Toxicity

Somnolence (sleepiness or unusual drowsiness), restlessness, irritability

Cetirizinum [Latin] Patient Information

Cetirizinum [Latin] Organisms Affected

Humans and other mammals